HOME >> MEDICINE >> NEWS
Regulator of lipid metabolism ensures high quality breast milk

La Jolla, CA Mouse mammary glands deficient in PPAR, a nuclear receptor that regulates the storage of fat, produce toxic milk that causes inflammation and baldness in suckling pups, report scientists at the Salk Institute for Biological Studies.

We were quite surprised by the unexpected quality control mechanism that ensures the quality of breast milk, says Ronald M. Evans, Ph.D., professor in the Salk Institutes Gene Expression Laboratory and a Howard Hughes Medical Investigator. Our finding explains why breast milk is always clean and healthful, even when theres a lot of inflammation going on in the mothers body, he adds.

The Salk research team led by Evans published their findings in the August issue of the journal Genes & Development. They hope that a better understanding of PPAR could help explain the role lipids and inflammation play in hair loss and other skin disorders and facilitate the development of new treatments for these diseases.

PPAR acts as a genetic switch, sensitizing the body to insulin and lowering levels of circulating glucose. In fact PPAR drugs, including Actos and Avandia, belong to the newest generation of anti-diabetic medications. Naturally occurring mutations in PPAR lead to obesity and insulin resistance associated with type 2 diabetes.

Unexpectedly, postdoctoral researcher and first author Yihong Wan, Ph.D., observed that mice lacking PPAR in endothelial cells had trouble rearing their newborns. Although the mothers seemed perfectly normal, the nursing offspring soon stopped growing and lost their hair, says Wan. It took us some time to figure out what was going on.

If the pups were given anti-inflammatory drugs such as aspirin or ibuprofen, the symptoms reversed and their fur started to regrow. These observations suggested that the milk produced by the mutant mice may be the source of the troubles, explained Wan. A closer inspection revealed that the milk of PPAR-deficient mice c
'"/>

Contact: Gina Kirchweger
Kirchweger@salk.edu
858-453-4100 x1340
Salk Institute
13-Aug-2007


Page: 1 2

Related medicine news :

1. Regulatory pathway in brain development possible basis for malformations
2. Race/ethnicity predict lipids, heart-disease risk in HIV-1 patients on protease inhibitors
3. Cholesterol levels and use of lipid-lowering drugs are not associated with breast cancer risk
4. Healthy weight means healthier blood lipid profile in children, study finds
5. ACTOS (pioglitazone HCl) significantly improved components of diabetic dyslipidemia
6. Penn study shows liver receptor key to diet-dependent differences in blood lipid levels
7. Controversy in dyslipidemia guidelines
8. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
9. Study identifies new regulator of fat metabolism
10. Risk of spina bifida associated with choline metabolism genes, but unrelated to choline intake
11. Abnormal glucose metabolism may contribute to chronic nerve disorder

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Regulator lipid metabolism ensures high quality breast milk

(Date:5/18/2013)... 18, 2013 Simple changes in a ... snacks and drinking more water can lead to substantial ... a healthier lifestyle overall. Diet Doc understands ... weight loss can be difficult and often requires the ... plans to help patients get over initial weight loss ...
(Date:5/18/2013)... 2013 Adolescents, especially young males, who ... or “K2” are landing in emergency rooms across America. ... drug epidemic with a new treatment program for ... to research from the National Institute on Drug Abuse, ... among American teenagers. In 2012, 11 percent of high ...
(Date:5/18/2013)... The California College of Ayurveda Spa is ... Ayurvedic Spa , the client receives stress relief therapies ... lifestyle recommendations and stress management techniques by a Clinical ... traditional healthcare system of India. It is based on ... basis for all optimum health. Ayurveda believes that where ...
(Date:5/18/2013)... May 18, 2013 Losing weight remains to ... among the horde of new weight loss products available in ... about. Recent studies about this newest weight loss supplement prove ... body shape. , Garcinia Cambogia is a sub-tropical fruit that ... Eating the fruit can suppress a person’s appetite, while it ...
(Date:5/18/2013)... Wisconsin (PRWEB) May 18, 2013 Scott Tischler ... in 90 days. These five keys to losing weight played ... help and support of Scott Tischler, Troy was able to ... that any weight loss program should be approached with caution ... pain. These are the five keys to weight loss that ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2
(Date:5/17/2013)... 17, 2013 /PRNewswire-iReach/ -- The escalation of new ... placing renewed emphasis on alternate delivery technologies. Alternate ... number of factors are converging to create both ... their delivery device partners . These include new ... growing trend toward self-administration for chronic diseases, shifting ...
(Date:5/17/2013)... 17, 2013  Boehringer Ingelheim will contribute to ... the American Thoracic Society International Conference (ATS 2013) ... 17 – 22. Data will highlight ... treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® ... investigational compounds for asthma, idiopathic pulmonary fibrosis (IPF) ...
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
Cached News: